Published January 1, 2011
| Version v1
Journal article
Open
Carboxylic acid derivatives of histone deacetylase inhibitors induce full length SMN2 transcripts: a promising target for spinal muscular atrophy therapeutics
Creators
- 1. Hacettepe Univ, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey
- 2. Hacettepe Univ, Fac Pharm, Dept Pharmaceut Chem, TR-06100 Ankara, Turkey
- 3. Middle E Tech Univ, Dept Chem, TR-06531 Ankara, Turkey
Description
Introduction: Proximal spinal muscular atrophy (SMA) is a common autosomal recessively inherited neuromuscular disorder. It is caused by homozygous absence of the survival motor neuron 1 (SMN1) gene. SMN2, which modulates the severity of the disease, represents a major target for therapy. The aim of this study was to investigate whether SMN2 expression can be increased by caffeic acid, chlorogenic acid and curcumin, which are designed by modifications of the carboxylic acid class of histone deacetylase (HDAC) inhibitors.
Files
bib-17f3669a-48ab-4c97-bc8f-952b0731b1d0.txt
Files
(289 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:726bbbf0c4f6fa90bc3f6603bd99a9e5
|
289 Bytes | Preview Download |